Relevant bibliographies by topics / Acrodysostosis / Journal articles
To see the other types of publications on this topic, follow the link: Acrodysostosis.

Journal articles on the topic 'Acrodysostosis'

Author: Grafiati
Published: 12 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Acrodysostosis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Silve, C., E. Clauser, and A. Linglart. "Acrodysostosis." Hormone and Metabolic Research 44, no. 10 (July 19, 2012): 749–58. http://dx.doi.org/10.1055/s-0032-1316330.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Silve, C., C. Le-Stunff, E. Motte, Y. Gunes, A. Linglart, and E. Clauser. "Acrodysostosis syndromes." BoneKEy Reports 1 (November 21, 2012): 225. http://dx.doi.org/10.1038/bonekey.2012.225.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

DAVIES, S. J., and H. E. HUGHES. "Familial acrodysostosis." Clinical Dysmorphology 1, no. 4 (October 1992): 207???216. http://dx.doi.org/10.1097/00019605-199210000-00003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Joshi, R. M., A. L. Pandya, B. A. Bharucha, Ravi Ramakantan, and N. B. Kumta. "Acrodysostosis syndrome." Indian Journal of Pediatrics 54, no. 2 (March 1987): 271–73. http://dx.doi.org/10.1007/bf02750824.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kirnap, Mehmet, Mustafa Calis, Cumali Gokce, Selim Kurtoglu, Mustafa Ozturk, and Fahrettin Kelestimur. "Acrodysostosis associated with hypercalcemia." HORMONES 12, no. 2 (April 15, 2013): 309–11. http://dx.doi.org/10.14310/horm.2002.1416.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hiers, Paul S., and Henry J. Rohrs. "UNEXPECTED HYPERPARATHYROIDISM IN A PATIENT WITH ACRODYSOSTOSIS." AACE Clinical Case Reports 6, no. 6 (November 2020): e326-e329. http://dx.doi.org/10.4158/accr-2020-0103.

Full text
Abstract:
Objective: Acrodysostosis is a rare skeletal dysplasia with one gene mutation associated with pseudohypoparathyroidism. We describe a 15-year-old male patient with genetic acrodysostosis who presented with hyperparathyroidism. Methods: Laboratory testing, including genetic testing for acrodysostosis and biochemical evaluation for hypercalcemia, were obtained. For evaluation of the source of hyperparathyroidism, parathyroid imaging including technetium (99mTc) sestamibi (MIBI) scan, ultrasound, and 4-dimensional computed tomography scans were performed. Results: The initial calcium level of 11.7 mg/dL (reference range is 8.4 to 10.2 mg/dL), phosphorus of 2.6 mg/dL (reference range is 2.9 to 5.0 mg/dL), and parathyroid hormone (PTH) of 177 pg/mL (reference range is 15 to 65 pg/mL) were suspicious for hyperparathyroidism. Magnesium, albumin, creatinine, and PTH-related peptide levels were normal. His calcium/creatinine ratio was 0.15, calcium/creatinine clearance ratio was 0.008, and the fractional excretion of phosphorus was 34%. Our patient had no symptoms other than long-standing bone pain. Thyroid ultrasound then MIBI scan did not show a parathyroid adenoma or parathyroid gland hyperplasia. Familial hypocalciuric hypercalcemic syndrome was entertained, but without a family history and documented normal calcium levels throughout childhood, it was considered unlikely. On subsequent testing, his calcium and PTH levels increased. Subsequent imaging including repeat thyroid ultrasound, MIBI scan, and computed tomography did not find a definitive cause. Multiple endocrine neoplasia type 1 genetic testing was negative. Without an adenoma seen to remove surgically, we performed a trial of cinacalcet with successful reduction in PTH and normalization of his calcium and phosphorus levels. Conclusion: Pseudohypoparathyroidism and hypocalcemia are well reported in acrodysostosis. To the best of our knowledge, this is the first reported case of hypercalcemia caused by hyperparathyroidism in a patient with acrodysostosis.
APA, Harvard, Vancouver, ISO, and other styles
7

Viljoen, Denis, and Peter Beighton. "Epiphyseal stippling in acrodysostosis." American Journal of Medical Genetics 38, no. 1 (January 1, 1991): 43–45. http://dx.doi.org/10.1002/ajmg.1320380111.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Vasava, Roopal, Bhargav Tank, and Abhilasha Jain. "A case of acrodysostosis: a rare primary bone dysplasia." International Journal of Research in Medical Sciences 6, no. 6 (May 25, 2018): 2165. http://dx.doi.org/10.18203/2320-6012.ijrms20182307.

Full text
Abstract:
Acrodysostosis is a rare skeletal dysplasia characterized by brachydactyly, facial dysostosis and nasal hypoplasia. Diagnostic approach to this disorder is based on clinical, radiological and hormonal assays. We present a case of 11-year-old female child who presented with the complaint of short stubby hands and feet since birth and facial dysmorphism. Her skeletal survey revealed typical radiographic features of acrodysostosis. Hormonal assays did not reveal any significant abnormality. In this case report, we would like to highlight the clinical and radiological features of this disorder which could be helpful in diagnosis of this rare disease.
APA, Harvard, Vancouver, ISO, and other styles
9

Singh, Arvinder, Manjeet Kaur,, and Sohan Singh. "ACRODYSOSTOSIS - A RARE SKELETAL DYSPLASIA." Journal of Evolution of Medical and Dental sciences 2, no. 29 (July 18, 2013): 5342–48. http://dx.doi.org/10.14260/jemds/993.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

STEINER, R. D., and R. A. PAGON. "Autosomal dominant transmission of acrodysostosis." Clinical Dysmorphology 1, no. 4 (October 1992): 201???206. http://dx.doi.org/10.1097/00019605-199210000-00002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Lahoud, Georges Abi, Nohra Chalouhi, and Pascal Jabbour. "Acrodysostosis and Spinal Canal Involvement." World Neurosurgery 82, no. 3-4 (September 2014): 537.e9–537.e11. http://dx.doi.org/10.1016/j.wneu.2013.03.071.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Macnicol, MF, and D. Makris. "Acrodysostosis and protrusio acetabuli. An association." Journal of Bone and Joint Surgery. British volume 70-B, no. 1 (January 1988): 38–39. http://dx.doi.org/10.1302/0301-620x.70b1.3339057.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Hamanishi, Chiaki, Yukio Nagata, Yosiaki Nagao, Satosi Sohen, and Seisuke Tanaka. "Acrodysostosis Associated with Spinal Canal Stenosis." Spine 18, no. 13 (October 1993): 1922–25. http://dx.doi.org/10.1097/00007632-199310000-00035.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Linglart, Agnès, Christine Menguy, Alain Couvineau, Colette Auzan, Yasemin Gunes, Mathilde Cancel, Emmanuelle Motte, et al. "RecurrentPRKAR1AMutation in Acrodysostosis with Hormone Resistance." New England Journal of Medicine 364, no. 23 (June 9, 2011): 2218–26. http://dx.doi.org/10.1056/nejmoa1012717.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Silve, Caroline. "Acrodysostosis: A new form of pseudohypoparathyroidism?" Annales d'Endocrinologie 76, no. 2 (May 2015): 110–12. http://dx.doi.org/10.1016/j.ando.2015.03.004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Li, Nan, Min Nie, Mei Li, Yan Jiang, Xiaoping Xing, Ou Wang, Chunlin Li, and Weibo Xia. "The First Mutation Identified in a Chinese Acrodysostosis Patient Confirms a p.G289E Variation of PRKAR1A Causes Acrodysostosis." International Journal of Molecular Sciences 15, no. 8 (July 29, 2014): 13267–74. http://dx.doi.org/10.3390/ijms150813267.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Ko, Jung Min, Kyu Sung Kwack, Sang-Hyun Kim, and Hyon-Ju Kim. "Acrodysostosis Associated with Symptomatic Cervical Spine Stenosis." Journal of Genetic Medicine 7, no. 2 (December 31, 2010): 145–50. http://dx.doi.org/10.5734/jgm.2010.7.2.145.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Lee, Hane, John M. Graham, David L. Rimoin, Ralph S. Lachman, Pavel Krejci, Stuart W. Tompson, Stanley F. Nelson, Deborah Krakow, and Daniel H. Cohn. "Exome Sequencing Identifies PDE4D Mutations in Acrodysostosis." American Journal of Human Genetics 90, no. 4 (April 2012): 746–51. http://dx.doi.org/10.1016/j.ajhg.2012.03.004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Sezer, Nebahat, Serap Tomruk Sutbeyaz, Fusun Koseoglu, Meltem Aras, and Ceyda Akın. "Adult case of acrodysostosis with severe neurologic involvement." Journal of Back and Musculoskeletal Rehabilitation 22, no. 2 (June 10, 2009): 125–29. http://dx.doi.org/10.3233/bmr-2009-0223.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Muhn, F., E. Klopocki, L. Graul-Neumann, S. Uhrig, A. Colley, M. Castori, E. Lankes, et al. "Novel mutations of thePRKAR1Agene in patients with acrodysostosis." Clinical Genetics 84, no. 6 (February 21, 2013): 531–38. http://dx.doi.org/10.1111/cge.12106.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Jalabert, Maud, François Rannou, and Christelle Nguyen. "Radicular claudication revealing possible acrodysostosis: A case report." Annals of Physical and Rehabilitation Medicine 61, no. 1 (January 2018): 60–61. http://dx.doi.org/10.1016/j.rehab.2017.06.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Stockman, J. A. "Recurrent PRKAR1A Mutation in Acrodysostosis with Hormone Resistance." Yearbook of Pediatrics 2013 (January 2013): 151–53. http://dx.doi.org/10.1016/j.yped.2011.10.019.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Gupte, Girish L., Archana S. Kher, Sanjeevani P. Kanade, Burjor A. Bharucha, and Sharad N. Sagade. "Acrodysostosis with 5α reductase deficiency: An unsual association." Indian Journal of Pediatrics 61, no. 3 (May 1994): 287–90. http://dx.doi.org/10.1007/bf02752226.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Hernández, Rosa María, Antonio Miranda, and Susana Kofman-Alfaro. "Acrodysostosis in two generations: an autosomal dominant syndrome." Clinical Genetics 39, no. 5 (June 28, 2008): 376–82. http://dx.doi.org/10.1111/j.1399-0004.1991.tb03045.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Nii, Eiji, Masao Urawa, Toshiko Nshimura, Hiroshi Kitou, Shiro Ikegawa, Shin Shimizu, Hiroshi Taneda, Atsumasa Uchida, and Norio Niikawa. "Acrodysostosis with unusual iridal color changing with age." American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 144B, no. 6 (2007): 824–25. http://dx.doi.org/10.1002/ajmg.b.30492.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Briet, Claire, Arrate Pereda, Catherine Le Stunff, Emmanuelle Motte, Juan de Dios Garcia-Diaz, Guiomar Perez de Nanclares, Nicolas Dumaz, and Caroline Silve. "Mutations causing acrodysostosis-2 facilitate activation of phosphodiesterase 4D3." Human Molecular Genetics 26, no. 20 (July 17, 2017): 3883–94. http://dx.doi.org/10.1093/hmg/ddx271.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Giedion, Andres. "Acrodysostosis and craniofacial conodysplasia are two separate bone dysplasias." Pediatric Radiology 32, no. 3 (January 24, 2002): 214. http://dx.doi.org/10.1007/s00247-001-0635-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Ueyama, Kaoru, Noriyuki Namba, Taichi Kitaoka, Keiko Yamamoto, Makoto Fujiwara, Yasuhisa Ohata, Takuo Kubota, and Keiichi Ozono. "Endocrinological and phenotype evaluation in a patient with acrodysostosis." Clinical Pediatric Endocrinology 26, no. 3 (2017): 177–82. http://dx.doi.org/10.1297/cpe.26.177.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Michot, Caroline, Carine Le Goff, Alice Goldenberg, Avinash Abhyankar, Céline Klein, Esther Kinning, Anne-Marie Guerrot, et al. "Exome Sequencing Identifies PDE4D Mutations as Another Cause of Acrodysostosis." American Journal of Human Genetics 90, no. 4 (April 2012): 740–45. http://dx.doi.org/10.1016/j.ajhg.2012.03.003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Lynch, Danielle C., David A. Dyment, Lijia Huang, Sarah M. Nikkel, Didier Lacombe, Philippe M. Campeau, Brendan Lee, et al. "Identification of Novel Mutations ConfirmsPde4das a Major Gene Causing Acrodysostosis." Human Mutation 34, no. 1 (November 9, 2012): 97–102. http://dx.doi.org/10.1002/humu.22222.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Velasco, Harvy M., Ehsan Ullah, Angela M. Martin, Robert B. Hufnagel, and Carlos E. Prada. "Novel progressive acrodysostosis‐like skeletal dysplasia, cerebellar atrophy, and ichthyosis." American Journal of Medical Genetics Part A 182, no. 10 (August 11, 2020): 2214–21. http://dx.doi.org/10.1002/ajmg.a.61782.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Mitsui, Toshikatsu, Ok-Hwa Kim, Christine M. Hall, Amaka Offiah, Diana Johnson, Dong-Kyu Jin, Teck-Hock Toh, et al. "Acroscyphodysplasia as a phenotypic variation of pseudohypoparathyroidism and acrodysostosis type 2." American Journal of Medical Genetics Part A 164, no. 10 (July 10, 2014): 2529–34. http://dx.doi.org/10.1002/ajmg.a.36669.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Lee, Benjamin Joseph, Lance Villeneuve, and Michael Martin. "Laminectomy as treatment for abrupt neurological decline in acrodysostosis: A case report." Surgical Neurology International 13 (October 21, 2022): 476. http://dx.doi.org/10.25259/sni_685_2022.

Full text
Abstract:
Background: Acrodysostosis (ACRO) is a rare disorder of peripheral bone development which can be either sporadic or inherited with mutations in the PRKAR1A or PDE4D genes. The resulting phenotypical characteristics are variable and overlap with other dysostosis conditions, making diagnosis difficult without genotyping. Vertebral malformations have been reported with ACRO resulting in slowly progressive spinal cord compression leading to radiculopathy or myelopathy. Case Description: A 19-year-old female diagnosed with ACRO presented with progressively worsening lower extremity paraparesis, sensory loss, and urinary retention; she was wheelchair-bound. A magnetic resonance imaging showed cord signal change at the T2/T3 levels with accompanying diffuse cord edema between T6-T8. Six months following a T2/T3 and T6/T7 laminectomy, the patient’s symptoms improved, but she still required a wheelchair. Conclusion: Patients with ACRO should be regularly monitored for cord compression to allow for early surgical decompression to prevent long-term, devasting neurological compromise.
APA, Harvard, Vancouver, ISO, and other styles
34

Wilson, L. C., M. E. Oude Luttikhuis, M. Baraitser, H. M. Kingston, and R. C. Trembath. "Normal erythrocyte membrane Gs alpha bioactivity in two unrelated patients with acrodysostosis." Journal of Medical Genetics 34, no. 2 (February 1, 1997): 133–36. http://dx.doi.org/10.1136/jmg.34.2.133.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Michot, Caroline, Carine Le Goff, Edward Blair, Patricia Blanchet, Yline Capri, Brigitte Gilbert-Dussardier, Alice Goldenberg, et al. "Expanding the phenotypic spectrum of variants in PDE4D/PRKAR1A: from acrodysostosis to acroscyphodysplasia." European Journal of Human Genetics 26, no. 11 (July 13, 2018): 1611–22. http://dx.doi.org/10.1038/s41431-018-0135-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Bruystens, Jessica GH, Jian Wu, Audrey Fortezzo, Jason Del Rio, Cole Nielsen, Donald K. Blumenthal, Ruth Rock, Eduard Stefan, and Susan S. Taylor. "Structure of a PKA RIα Recurrent Acrodysostosis Mutant Explains Defective cAMP-Dependent Activation." Journal of Molecular Biology 428, no. 24 (December 2016): 4890–904. http://dx.doi.org/10.1016/j.jmb.2016.10.033.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Amarasena, Sujeewa, M. G. K. Samanlatha, M. H. A. D. De Silva, and P. Kolombage. "A 12 year old girl with acrodysostosis: a rare cause of short stature." Sri Lanka Journal of Child Health 38, no. 2 (July 11, 2009): 72. http://dx.doi.org/10.4038/sljch.v38i2.684.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Linglart, Agnès, Helena Fryssira, Olaf Hiort, Paul-Martin Holterhus, Guiomar Perez de Nanclares, Jesús Argente, Claudine Heinrichs, et al. "PRKAR1AandPDE4DMutations Cause Acrodysostosis but Two Distinct Syndromes with or without GPCR-Signaling Hormone Resistance." Journal of Clinical Endocrinology & Metabolism 97, no. 12 (December 1, 2012): E2328—E2338. http://dx.doi.org/10.1210/jc.2012-2326.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Rhayem, Yara, Catherine Le Stunff, Waed Abdel Khalek, Colette Auzan, Jerome Bertherat, Agnès Linglart, Alain Couvineau, Caroline Silve, and Eric Clauser. "Functional Characterization ofPRKAR1AMutations Reveals a Unique Molecular Mechanism Causing Acrodysostosis but Multiple Mechanisms Causing Carney Complex." Journal of Biological Chemistry 290, no. 46 (September 24, 2015): 27816–28. http://dx.doi.org/10.1074/jbc.m115.656553.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Del-rio, Jason, Leon Wu, Tsanwen Lu, Phillip Aoto, and Susan S. Taylor. "Functional and Structural Characterization of Acrodysostosis Mutations of PKA RIα Reveals Mechanism Causing resistant to cAMP activation." FASEB Journal 34, S1 (April 2020): 1. http://dx.doi.org/10.1096/fasebj.2020.34.s1.05949.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Nagasaki, Keisuke, Tomoko Iida, Hidetoshi Sato, Yohei Ogawa, Toru Kikuchi, Akihiko Saitoh, Tsutomu Ogata, and Maki Fukami. "PRKAR1AMutation Affecting cAMP-Mediated G Protein-Coupled Receptor Signaling in a Patient with Acrodysostosis and Hormone Resistance." Journal of Clinical Endocrinology & Metabolism 97, no. 9 (September 1, 2012): E1808—E1813. http://dx.doi.org/10.1210/jc.2012-1369.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Butler, Merlin G., Laura J. Rames, and William B. Wadlington. "Acrodysostosis: Report of a 13-year-old boy with review of literature and metacarphphalangeal pattern profile analysis." American Journal of Medical Genetics 30, no. 4 (August 1988): 971–80. http://dx.doi.org/10.1002/ajmg.1320300416.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Bolger, Graeme B., Lisa High Mitchell Smoot, and Thomas van Groen. "Dominant-Negative Attenuation of cAMP-Selective Phosphodiesterase PDE4D Action Affects Learning and Behavior." International Journal of Molecular Sciences 21, no. 16 (August 9, 2020): 5704. http://dx.doi.org/10.3390/ijms21165704.

Full text
Abstract:
PDE4 cyclic nucleotide phosphodiesterases reduce 3′, 5′ cAMP levels in the CNS and thereby regulate PKA activity and the phosphorylation of CREB, fundamental to depression, cognition, and learning and memory. The PDE4 isoform PDE4D5 interacts with the signaling proteins β-arrestin2 and RACK1, regulators of β2-adrenergic and other signal transduction pathways. Mutations in PDE4D in humans predispose to acrodysostosis, associated with cognitive and behavioral deficits. To target PDE4D5, we developed mice that express a PDE4D5-D556A dominant-negative transgene in the brain. Male transgenic mice demonstrated significant deficits in hippocampus-dependent spatial learning, as assayed in the Morris water maze. In contrast, associative learning, as assayed in a fear conditioning assay, appeared to be unaffected. Male transgenic mice showed augmented activity in prolonged (2 h) open field testing, while female transgenic mice showed reduced activity in the same assay. Transgenic mice showed no demonstrable abnormalities in prepulse inhibition. There was also no detectable difference in anxiety-like behavior, as measured in the elevated plus-maze. These data support the use of a dominant-negative approach to the study of PDE4D5 function in the CNS and specifically in learning and memory.
APA, Harvard, Vancouver, ISO, and other styles
44

Graham Jr., John M., Deborah Krakow, Vernon T. Tolo, Andrew K. Smith, and R. S. Lachman. "Radiographic findings and Gs-alpha bioactivity studies and mutation screening in acrodysostosis indicate a different etiology from pseudohypoparathyroidism." Pediatric Radiology 31, no. 1 (January 1, 2001): 2–9. http://dx.doi.org/10.1007/s002470000355.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Jafari, Naeimeh, Jason Del Rio, Madoka Akimoto, Jung Ah Byun, Stephen Boulton, Kody Moleschi, Yousif Alsayyed, et al. "Noncanonical protein kinase A activation by oligomerization of regulatory subunits as revealed by inherited Carney complex mutations." Proceedings of the National Academy of Sciences 118, no. 21 (May 18, 2021): e2024716118. http://dx.doi.org/10.1073/pnas.2024716118.

Full text
Abstract:
Familial mutations of the protein kinase A (PKA) R1α regulatory subunit lead to a generalized predisposition for a wide range of tumors, from pituitary adenomas to pancreatic and liver cancers, commonly referred to as Carney complex (CNC). CNC mutations are known to cause overactivation of PKA, but the molecular mechanisms underlying such kinase overactivity are not fully understood in the context of the canonical cAMP-dependent activation of PKA. Here, we show that oligomerization-induced sequestration of R1α from the catalytic subunit of PKA (C) is a viable mechanism of PKA activation that can explain the CNC phenotype. Our investigations focus on comparative analyses at the level of structure, unfolding, aggregation, and kinase inhibition profiles of wild-type (wt) PKA R1α, the A211D and G287W CNC mutants, as well as the cognate acrodysostosis type 1 (ACRDYS1) mutations A211T and G287E. The latter exhibit a phenotype opposite to CNC with suboptimal PKA activation compared with wt. Overall, our results show that CNC mutations not only perturb the classical cAMP-dependent allosteric activation pathway of PKA, but also amplify significantly more than the cognate ACRDYS1 mutations nonclassical and previously unappreciated activation pathways, such as oligomerization-induced losses of the PKA R1α inhibitory function.
APA, Harvard, Vancouver, ISO, and other styles
46

Kaname, Tadashi, Chang-Seok Ki, Norio Niikawa, George S. Baillie, Jonathan P. Day, Ken-ichi Yamamura, Tohru Ohta, et al. "Heterozygous mutations in cyclic AMP phosphodiesterase-4D (PDE4D) and protein kinase A (PKA) provide new insights into the molecular pathology of acrodysostosis." Cellular Signalling 26, no. 11 (November 2014): 2446–59. http://dx.doi.org/10.1016/j.cellsig.2014.07.025.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Thiele, Susanne, Giovanna Mantovani, Anne Barlier, Valentina Boldrin, Paolo Bordogna, Luisa De Sanctis, Francesca M. Elli, et al. "From pseudohypoparathyroidism to inactivating PTH/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP network." European Journal of Endocrinology 175, no. 6 (December 2016): P1—P17. http://dx.doi.org/10.1530/eje-16-0107.

Full text
Abstract:
Objective Disorders caused by impairments in the parathyroid hormone (PTH) signalling pathway are historically classified under the term pseudohypoparathyroidism (PHP), which encompasses rare, related and highly heterogeneous diseases with demonstrated (epi)genetic causes. The actual classification is based on the presence or absence of specific clinical and biochemical signs together with an in vivo response to exogenous PTH and the results of an in vitro assay to measure Gsa protein activity. However, this classification disregards other related diseases such as acrodysostosis (ACRDYS) or progressive osseous heteroplasia (POH), as well as recent findings of clinical and genetic/epigenetic background of the different subtypes. Therefore, the EuroPHP network decided to develop a new classification that encompasses all disorders with impairments in PTH and/or PTHrP cAMP-mediated pathway. Design and methods Extensive review of the literature was performed. Several meetings were organised to discuss about a new, more effective and accurate way to describe disorders caused by abnormalities of the PTH/PTHrP signalling pathway. Results and conclusions After determining the major and minor criteria to be considered for the diagnosis of these disorders, we proposed to group them under the term ‘inactivating PTH/PTHrP signalling disorder’ (iPPSD). This terminology: (i) defines the common mechanism responsible for all diseases; (ii) does not require a confirmed genetic defect; (iii) avoids ambiguous terms like ‘pseudo’ and (iv) eliminates the clinical or molecular overlap between diseases. We believe that the use of this nomenclature and classification will facilitate the development of rationale and comprehensive international guidelines for the diagnosis and treatment of iPPSDs.
APA, Harvard, Vancouver, ISO, and other styles
48

Le Stunff, Catherine, Francoise Tilotta, Jérémy Sadoine, Dominique Le Denmat, Claire Briet, Emmanuelle Motte, Eric Clauser, Pierre Bougnères, Catherine Chaussain, and Caroline Silve. "Knock-In of the Recurrent R368X Mutation of PRKAR1A that Represses cAMP-Dependent Protein Kinase A Activation: A Model of Type 1 Acrodysostosis." Journal of Bone and Mineral Research 32, no. 2 (October 24, 2016): 333–46. http://dx.doi.org/10.1002/jbmr.2987.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Motte, Emmanuelle, Catherine Le Stunff, Claire Briet, Nicolas Dumaz, and Caroline Silve. "Modulation of signaling through GPCR-cAMP-PKA pathways by PDE4 depends on stimulus intensity: Possible implications for the pathogenesis of acrodysostosis without hormone resistance." Molecular and Cellular Endocrinology 442 (February 2017): 1–11. http://dx.doi.org/10.1016/j.mce.2016.11.026.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Motte, E., C. Le Stunff, A. Linglart, and C. Silve. "Absence of renal resistance to PTH in PDE4D-mutated acrodysostosis patients: Regulation of cAMP/PKA pathway by PDE4 may be tissue and agonist-specific – example of renal PTH signaling pathway." Annales d'Endocrinologie 74, no. 4 (September 2013): 294. http://dx.doi.org/10.1016/j.ando.2013.07.170.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography